Price: 53.7

Today's Change: 0.2

Today's Percent Change: 0.37%

Today's Volume: 244651

Average Daily Volume: 303231

52 week low: 38.3

52 week high: 62.95

Market cap: 1760000000.0

EBITDA: 167230000.0

EBITDA / market_cap: 9.50%

Earnings per Share (EPS): 2.74

EPS / price: 5.10%

Dividend Yield: 0.0%

Dividend per share: 0.0

Book value: 14.38

Price to Book Ratio: 3.72

Price to Earnings (P/E) Ratio: 19.56

Price to Earnings Growth (PEG) Ratio: 1.16

Price to Sales (P/S) Ratio: 3.4

Short Ratio: 9.07

Exchange: "NYQ"

Short term: DOWN (Previous: UP)

Mid term: DOWN (Previous: UP)

Long term: DOWN (Previous: UP)

Support: 52.83

Resistance: 53.83

Pivot point: 53.22

SMA 10: 56.70

SMA 50: 54.31

SMA 100: 54.23

RSI 10: 32.36

RSI 50: 49.69

RSI 100: 50.99

EMA 10: 57.27

EMA 50: 53.86

EMA 100: 54.13


Based on 1 buy signal and 11 sell signals

Previous signal: strong sell




@thefinreviewer: Westfield Capital Management Company LP Has Cut Its Berry Global Group $BERY Holding; Cambrex $CBM Shorts Down By 9…

@BlogYomi: Comparison of Amarin Corporation plc $CBM

@thefinreviewer: Sarepta Therapeutics Inc. $CBM Comparing side by side

@BlogYomi: ARCA biopharma Inc. $CBM

@OlympiaReport: Zacks: Brokerages Anticipate Cambrex Co. $CBM to Post $0.53 Earnings Per Share

@WeekHerald: Brokerages Anticipate Cambrex Co. $CBM to Announce $0.53 EPS

@BinanceAlert: Start now trading $CBM #CBM (Crypto Bonus Miles Token) at #Binance 📈 BTC/ETH #Huobi #OKEx #Bittrex

@bulletin_en: Cambrex Corporation $CBM Ratings Summary as of Mar 19, 2019

@thefinreviewer: Puma Biotechnology Inc. $CBM Contrasting side by side

@AmericanBanking: Cambrex Co. $CBM Receives Consensus Rating of “Buy” from Analysts #stocks

@TheMarketsDaily: Cambrex Co. $CBM Given Consensus Recommendation of “Buy” by Analysts

@macondailynews: Cambrex Co. $CBM Receives Consensus Rating of “Buy” from Analysts

@thefinreviewer: Mirati Therapeutics Inc. $CBM

@ShuvroA50775263: @aeron_aero When will add $CBM in Exchange? Please give information about $CBM.